Trial · NCT05029622
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants With Luteinising Hormone (LH) Suppression | At Month 6 | The ITT population consisted of all participants who received at least 1 dose of study intervention. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With LH Response to GnRH Test | At Months 3 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in Basal Serum LH and Follicle-Stimulating Hormone (FSH) Levels | Baseline and at Months 3, 6, 9 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | IU/L | MEAN |
| SECONDARY | Change From Baseline in Peak Serum LH and FSH Level After the GnRH Stimulation Test | Baseline and at Months 3, 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | IU/L | MEAN |
| SECONDARY | Percentage of Participants With LH Response (Peak LH <=5 IU/L) From Month 6 to Month 12 | Month 6 to Month 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Prepubertal Levels of Sex Steroids | At Months 3, 6, 9 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in Mean Height for Age (Z-Score) | Baseline and at Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | Z-score | MEAN |
| SECONDARY | Change From Baseline in Percentile for Height for Age | Baseline and at Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | percentiles of Z-score | MEAN |
| SECONDARY | Change From Baseline in Growth Velocity | Baseline and at Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | centimeter (cm)/year | MEAN |
| SECONDARY | Percentage of Participants With Bone Age (BA)/Chronological Age (CA) Ratio Not Risen | At Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in BA:CA Ratio | Baseline, Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | ratio | MEAN |
| SECONDARY | Percentage of Participants With Stabilized Pubertal Stage | At Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Regression of Uterine Length | At Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the female participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With Absence of Progression of Testis Volumes | At Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the male participants analyzed were reported. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in Body Mass Index (BMI) | Baseline and at Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | kilogram (kg)/meter square | MEAN |
| SECONDARY | Change From Baseline in Weight | Baseline and at Months 6 and 12 | The ITT population consisted of all participants who received at least 1 dose of study intervention. Only data from the participants analyzed were reported. | kg | MEAN |
| SECONDARY | Plasma Concentrations of Triptorelin | Day 1, 4 hours post-injection; Month 3; Month 6, predose; Month 6, 4 hours post-injection; and Month 12 | The Pharmacokinetic (PK) set consisted of all participants who received at 1 dose of study treatment and had at least 1 valid triptorelin concentration. Only data from the participants analyzed were reported. | ng/mL | GEOMETRIC_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05029622/outcomes